Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$58.92 -1.08 (-1.81%)
As of: Oct 1, 2026 · 2:16 PM EDT

Biomarin Pharmaceutical (BMRN) Interest Expenses (2009 - 2026)

Updated

Biomarin Pharmaceutical (BMRN) posted Interest Expenses of $63.3 million for Q2 2026, compared with $2.68 million a year earlier and up 323.2% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Interest Expenses (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest Expenses at Biomarin Pharmaceutical was $83.61 million, up 654.1% year-over-year; for FY2025, it was $10.9 million, down 14.0% from FY2024.

  • Annual Interest Expenses shows a five-year compound annual growth rate of -18.0% (FY2020 to FY2025).
  • In prior years, Biomarin Pharmaceutical's Interest Expenses was $12.67 million in FY2024 (-26.9%), $17.34 million in FY2023 (+8.5%), $15.97 million in FY2022 (+4.1%) and $15.34 million in FY2021 (-47.7%).
  • The Q2 2026 figure stands as the highest quarterly Interest Expenses in data going back to Q2 2009.
  • On a year-over-year basis, Interest Expenses increased in two of the last seven quarters, with growth averaging 41.9%.
  • The strongest year-over-year quarter for Interest Expenses in the past five years was Q1 2026, with growth of 422.5%; the weakest was Q3 2021, with a decline of 59.7%.
  • According to Business Quant data, Interest Expenses for the three prior quarters was $14.96 million (Q1 2026), $2.78 million (Q4 2025) and $2.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Biomarin Pharmaceutical 11.61 Bn 5.48 Bn 786.91 Mn 63.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.30 Mn
Mar 31, 2026 14.96 Mn
Dec 31, 2025 2.78 Mn
Sep 30, 2025 2.58 Mn
Jun 30, 2025 2.68 Mn
Mar 31, 2025 2.86 Mn
Dec 31, 2024 2.58 Mn
Sep 30, 2024 2.97 Mn
Jun 30, 2024 3.57 Mn
Mar 31, 2024 3.55 Mn
Dec 31, 2023 6.10 Mn
Sep 30, 2023 3.78 Mn
Jun 30, 2023 3.76 Mn
Mar 31, 2023 3.70 Mn
Dec 31, 2022 3.63 Mn
Sep 30, 2022 4.68 Mn
Jun 30, 2022 3.86 Mn
Mar 31, 2022 3.81 Mn
Dec 31, 2021 3.85 Mn
Sep 30, 2021 3.87 Mn
API Access

Biomarin Pharmaceutical Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=BMRN&period=max&api_key=YOUR_API_KEY